FDA Drug Approvals Require Less Rigorous Evidence, Study Finds

January 15, 2020

An ongoing push to speed new medicines to patients has led to the growth of new Food and Drug Administration (FDA) programs with relaxed evidence standards for approving drugs, according to an analysis from researchers at Harvard Medical School and Brigham and Women’s Hospital.